UK markets open in 2 hours 51 minutes
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,406.04 +198.91 (+1.09%) CRUDE OIL
79.24 +0.29 (+0.37%) GOLD FUTURES
2,310.90 +1.30 (+0.06%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,567.69 +1,791.07 (+3.91%)
Asensus Surgical, Inc. (ASXC)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 66.72M |
| Enterprise value | 51.33M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.13 |
| Price/book (mrq) | 2.00 |
| Enterprise value/revenue | 5.98 |
| Enterprise value/EBITDA | -0.69 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.48 |
| 52-week change 3 | -61.90% |
| S&P500 52-week change 3 | 21.33% |
| 52-week high 3 | 0.6900 |
| 52-week low 3 | 0.2000 |
| 50-day moving average 3 | 0.2708 |
| 200-day moving average 3 | 0.2886 |
Share statistics
| Avg vol (3-month) 3 | 1.65M |
| Avg vol (10-day) 3 | 1M |
| Shares outstanding 5 | 272.31M |
| Implied shares outstanding 6 | 271.99M |
| Float 8 | 266.52M |
| % held by insiders 1 | 2.05% |
| % held by institutions 1 | 9.27% |
| Shares short (15 Apr 2024) 4 | 16.51M |
| Short ratio (15 Apr 2024) 4 | 5.96 |
| Short % of float (15 Apr 2024) 4 | 6.17% |
| Short % of shares outstanding (15 Apr 2024) 4 | 6.07% |
| Shares short (prior month 15 Mar 2024) 4 | 17.01M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 12 Dec 2019 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:13 |
| Last split date 3 | 12 Dec 2019 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -282.34% |
Management effectiveness
| Return on assets (ttm) | -55.76% |
| Return on equity (ttm) | -117.89% |
Income statement
| Revenue (ttm) | 8.58M |
| Revenue per share (ttm) | 0.03 |
| Quarterly revenue growth (yoy) | 120.40% |
| Gross profit (ttm) | N/A |
| EBITDA | -74.4M |
| Net income avi to common (ttm) | -78.43M |
| Diluted EPS (ttm) | -0.3100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 21.07M |
| Total cash per share (mrq) | 0.08 |
| Total debt (mrq) | 5.68M |
| Total debt/equity (mrq) | 17.00% |
| Current ratio (mrq) | 2.88 |
| Book value per share (mrq) | 0.13 |
Cash flow statement
| Operating cash flow (ttm) | -63.63M |
| Levered free cash flow (ttm) | -34.74M |
© 2024 Yahoo. All rights reserved.